Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension

Journal of Heart and Lung Transplantation

Volumn 37, Issue 3, 2018, Pages 376-384

  Prins, Kurt W ^a   Archer, Stephen L ^b   Pritzker, Marc ^a   Rose, Lauren ^a   Weir, E Kenneth ^a   Sharma, Alok ^c   Thenappan, Thenappan ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c HonorHealth and the Scottsdale Lincoln Health Network   (United States)

Author keywords

biomarkers; inflammation; interleukins; pulmonary hypertension; RV PA coupling

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6;

ADULT; ARTERY COMPLIANCE; ARTICLE; CARDIAC INDEX; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL ASSESSMENT; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; IMMUNOASSAY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; BLOOD; COMPLICATION; ETIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; INTERLEUKIN-6; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 85028868595     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2017.08.011     Document Type: Article

References (45)

1. Rabinovitch, M., Guignabert, C., Humbert, M., et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 115 (2014), 165–175.
2. Humbert, M., Monti, G., Brenot, F., et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151 (1995), 1628–1631.
3. Soon, E., Holmes, A.M., Treacy, C.M., et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122 (2010), 920–927.
4. Bhargava, A., Kumar, A., Yuan, N., et al. Monocrotaline induces interleukin-6 mRNA expression in rat lungs. Heart Dis 1 (1999), 126–132.
5. Miyata, M., Sakuma, F., Yoshimura, A., et al. Pulmonary hypertension in rats. 2. Role of interleukin-6. Int Arch Allergy Immunol 108 (1995), 287–291.
6. Matura, L.A., Ventetuolo, C.E., Palevsky, H.I., et al. Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension. Ann Am Thorac Soc 12 (2015), 370–375.
7. Heresi, G.A., Aytekin, M., Hammel, J.P., et al. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension. Eur Respir J 43 (2014), 912–914.
8. Steiner, M.K., Syrkina, O.L., Kolliputi, N., et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104 (2009), 236–244.
9. Savale, L., Tu, L., Rideau, D., et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res, 10, 2009, 6.
10. Hagen, M., Fagan, K., Steudel, W., et al. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 292 (2007), L1473–L1479.
11. Brock, M., Trenkmann, M., Gay, R.E., et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 104 (2009), 1184–1191.
12. Finkel, M.S., Oddis, C.V., Jacob, T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992), 387–389.
13. Kinugawa, K., Takahashi, T., Kohmoto, O., et al. Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. Circ Res 75 (1994), 285–295.
14. Villegas, S., Villarreal, F.J., Dillmann, W.H., Leukemia inhibitory factor and interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes. Basic Res Cardiol 95 (2000), 47–54.
15. Zhao, L., Cheng, G., Jin, R., et al. Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction. Circ Res 118 (2016), 1918–1929.
16. Zhang, Y., Wang, J.H., Zhang, Y.Y., et al. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways. Sci Rep, 6, 2016, 23010.
17. Yan, A.T., Yan, R.T., Cushman, M., et al. Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis. Eur Heart J 31 (2010), 875–882.
18. Torre-Amione, G., Kapadia, S., Benedict, C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996), 1201–1206.
19. Plenz, G., Song, Z.F., Tjan, T.D., et al. Activation of the cardiac interleukin-6 system in advanced heart failure. Eur J Heart Fail 3 (2001), 415–421.
20. Harhay, M.O., Tracy, R.P., Bagiella, E., et al. Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study. Int J Cardiol 168 (2013), 3818–3824.
21. Thenappan, T., Shah, S.J., Rich, S., et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 35 (2010), 1079–1087.
22. Humbert, M., Sitbon, O., Chaouat, A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173 (2006), 1023–1030.
23. Benza, R.L., Miller, D.P., Gomberg-Maitland, M., et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 122 (2010), 164–172.
24. Forfia, P.R., Fisher, M.R., Mathai, S.C., et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 174 (2006), 1034–1041.
25. van de Veerdonk, M.C., Kind, T., Marcus, J.T., et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 58 (2011), 2511–2519.
26. Prins, K.W., Weir, E.K., Archer, S.L., et al. Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension. Pulm Circ 6 (2016), 576–585.
27. LaFarge, C.G., Miettinen, O.S., The estimation of oxygen consumption. Cardiovasc Res 4 (1970), 23–30.
28. Mahapatra, S., Nishimura, R.A., Sorajja, P., et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 47 (2006), 799–803.
29. Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39 e14.
30. Steiner, J., Wu, W.C., Jankowich, M., et al. Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities. PLoS One, 10, 2015, e0119277.
31. Melenovsky, V., Hwang, S.J., Lin, G., et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35 (2014), 3452–3462.
32. Andersen, M.J., Hwang, S.J., Kane, G.C., et al. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Circ Heart Fail 8 (2015), 542–550.
33. Guazzi, M., Bandera, F., Pelissero, G., et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 305 (2013), H1373–H1381.
34. Guazzi, M., Naeije, R., Arena, R., et al. Echocardiography of right ventriculoarterial coupling combined with cardiopulmonary exercise testing to predict outcome in heart failure. Chest 148 (2015), 226–234.
35. Guazzi, M., Dixon, D., Labate, V., et al. RV contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction: stratification of clinical phenotypes and outcomes. JACC Cardiovasc Imaging 10 (2017), 1211–1221.
36. Ghio, S., Klersy, C., Magrini, G., et al. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 140 (2010), 272–278.
37. Nagendran, J., Archer, S.L., Soliman, D., et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116 (2007), 238–248.
38. Rain, S., Bos Dda, S., Handoko, M.L., et al. Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension. J Am Heart Assoc, 3, 2014, e000716.
39. Moon, M.R., Aziz, A., Lee, A.M., et al. Differential calcium handling in two canine models of right ventricular pressure overload. J Surg Res 178 (2012), 554–562.
40. Kögler, H., Hartmann, O., Leineweber, K., et al. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat. Circ Res 93 (2003), 230–237.
41. Xie, Y.P., Chen, B., Sanders, P., et al. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension. Hypertension 59 (2012), 355–362.
42. Barreto, D.V., Barreto, F.C., Liabeuf, S., et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 77 (2010), 550–556.
43. Plenz, G., Eschert, H., Erren, M., et al. The interleukin-6/interleukin-6-receptor system is activated in donor hearts. J Am Coll Cardiol 39 (2002), 1508–1512.
44. Yamauchi-Takihara, K., Ihara, Y., Ogata, A., et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91 (1995), 1520–1524.
45. West, J., Fagan, K., Steudel, W., et al. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94 (2004), 1109–1114.